231 related articles for article (PubMed ID: 22170068)
1. Pivotal role of ADP-ribosylation factor 6 in Toll-like receptor 9-mediated immune signaling.
Wu JY; Kuo CC
J Biol Chem; 2012 Feb; 287(6):4323-34. PubMed ID: 22170068
[TBL] [Abstract][Full Text] [Related]
2. ADP-Ribosylation Factor 3 Mediates Cytidine-Phosphate-Guanosine Oligodeoxynucleotide-Induced Responses by Regulating Toll-Like Receptor 9 Trafficking.
Wu JY; Kuo CC
J Innate Immun; 2015; 7(6):623-36. PubMed ID: 26067373
[TBL] [Abstract][Full Text] [Related]
3. TLR9-mediated ARF6 activation is involved in advancing CpG ODN cellular uptake.
Wu JY; Kuo CC
Commun Integr Biol; 2012 Jul; 5(4):316-8. PubMed ID: 23060951
[TBL] [Abstract][Full Text] [Related]
4. Ras participates in CpG oligodeoxynucleotide signaling through association with toll-like receptor 9 and promotion of interleukin-1 receptor-associated kinase/tumor necrosis factor receptor-associated factor 6 complex formation in macrophages.
Xu H; An H; Yu Y; Zhang M; Qi R; Cao X
J Biol Chem; 2003 Sep; 278(38):36334-40. PubMed ID: 12867418
[TBL] [Abstract][Full Text] [Related]
5. CpG-ODN, the TLR9 agonist, attenuates myocardial ischemia/reperfusion injury: involving activation of PI3K/Akt signaling.
Cao Z; Ren D; Ha T; Liu L; Wang X; Kalbfleisch J; Gao X; Kao R; Williams D; Li C
Biochim Biophys Acta; 2013 Jan; 1832(1):96-104. PubMed ID: 22917564
[TBL] [Abstract][Full Text] [Related]
6. Class I and III phosphatidylinositol 3'-kinase play distinct roles in TLR signaling pathway.
Kuo CC; Lin WT; Liang CM; Liang SM
J Immunol; 2006 May; 176(10):5943-9. PubMed ID: 16670302
[TBL] [Abstract][Full Text] [Related]
7. Leucine-rich repeat 11 of Toll-like receptor 9 can tightly bind to CpG-containing oligodeoxynucleotides, and the positively charged residues are critical for the high affinity.
Pan X; Yue J; Ding G; Li B; Liu X; Zheng X; Yu M; Li J; Jiang W; Wu C; Zheng J; Zhou H
J Biol Chem; 2012 Aug; 287(36):30596-609. PubMed ID: 22822061
[TBL] [Abstract][Full Text] [Related]
8. Involvement of heat shock protein (Hsp)90 beta but not Hsp90 alpha in antiapoptotic effect of CpG-B oligodeoxynucleotide.
Kuo CC; Liang CM; Lai CY; Liang SM
J Immunol; 2007 May; 178(10):6100-8. PubMed ID: 17475835
[TBL] [Abstract][Full Text] [Related]
9. CpG-oligodeoxynucleotide inhibits Smad-dependent bone morphogenetic protein signaling: effects on myeloma cell apoptosis and in vitro osteoblastogenesis.
Nørgaard NN; Holien T; Jönsson S; Hella H; Espevik T; Sundan A; Standal T
J Immunol; 2010 Sep; 185(6):3131-9. PubMed ID: 20702733
[TBL] [Abstract][Full Text] [Related]
10. Mannose receptor 1 mediates cellular uptake and endosomal delivery of CpG-motif containing oligodeoxynucleotides.
Moseman AP; Moseman EA; Schworer S; Smirnova I; Volkova T; von Andrian U; Poltorak A
J Immunol; 2013 Dec; 191(11):5615-24. PubMed ID: 24184555
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor agonists induce apoptosis in mouse B-cell lymphoma cells by altering NF-κB activation.
Arunkumar N; Liu C; Hang H; Song W
Cell Mol Immunol; 2013 Jul; 10(4):360-72. PubMed ID: 23727784
[TBL] [Abstract][Full Text] [Related]
12. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM
J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
[TBL] [Abstract][Full Text] [Related]
13. CpG-oligodeoxynucleotide-induced TLR9 activation regulates macrophage TREM-1 expression and shedding.
Molad Y; Pokroy-Shapira E; Carmon V
Innate Immun; 2013 Dec; 19(6):623-30. PubMed ID: 23475790
[TBL] [Abstract][Full Text] [Related]
14. CpG ODN 2102 promotes antibacterial immune responses and enhances vaccine-induced protection in golden pompano (Trachinotusovatus).
Chen X; Wu Y; Qiu Y; Li P; Cao Z; Zhou Y; Sun Y
Fish Shellfish Immunol; 2023 Jun; 137():108783. PubMed ID: 37137380
[TBL] [Abstract][Full Text] [Related]
15. Postconditioning with a CpG containing oligodeoxynucleotide ameliorates myocardial infarction in a murine closed-chest model.
Kim SC; Wu S; Fang X; Neumann J; Eichhorn L; Schleifer G; Boehm O; Meyer R; Frede S; Hoeft A; Baumgarten G; Knuefermann P
Life Sci; 2014 Dec; 119(1-2):1-8. PubMed ID: 25445440
[TBL] [Abstract][Full Text] [Related]
16. Novel immunostimulatory agent based on CpG oligodeoxynucleotide linked to the nontoxic B subunit of cholera toxin.
Adamsson J; Lindblad M; Lundqvist A; Kelly D; Holmgren J; Harandi AM
J Immunol; 2006 Apr; 176(8):4902-13. PubMed ID: 16585586
[TBL] [Abstract][Full Text] [Related]
17. Characterization of suppressive oligodeoxynucleotides that inhibit Toll-like receptor-9-mediated activation of innate immunity.
Peter M; Bode K; Lipford GB; Eberle F; Heeg K; Dalpke AH
Immunology; 2008 Jan; 123(1):118-28. PubMed ID: 17961163
[TBL] [Abstract][Full Text] [Related]
18. Recognition of CpG oligodeoxynucleotides by human Toll-like receptor 9 and subsequent cytokine induction.
Suwarti S; Yamazaki T; Svetlana C; Hanagata N
Biochem Biophys Res Commun; 2013 Jan; 430(4):1234-9. PubMed ID: 23266611
[TBL] [Abstract][Full Text] [Related]
19. A combination of Lox-1 and Nox1 regulates TLR9-mediated foam cell formation.
Lee JG; Lim EJ; Park DW; Lee SH; Kim JR; Baek SH
Cell Signal; 2008 Dec; 20(12):2266-75. PubMed ID: 18817866
[TBL] [Abstract][Full Text] [Related]
20. CpG oligonucleotide activates Toll-like receptor 9 and causes lung inflammation in vivo.
Knuefermann P; Baumgarten G; Koch A; Schwederski M; Velten M; Ehrentraut H; Mersmann J; Meyer R; Hoeft A; Zacharowski K; Grohé C
Respir Res; 2007 Oct; 8(1):72. PubMed ID: 17925007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
